- Erasca's $550M offering; Summit sells an antibioticPlus, news about subcutaneous Leqembi, WuXi AppTec and Q32 Bio. 📊 Erasca targets $550M for KRAS drugs: The biotech's public offering came after it shared a small ...Endpoints · 13d ago↗ source
- STAT+: Akero team, backed by Fairmount, launches new immunology companyFDA approves injectable Leqembi, another post-Makary reversal, and other biotech news from The ReadoutSTAT · 13d ago↗ source
- Chai Discovery gets $400M, tripling valuation from seven months agoChai Discovery, one of the hottest startups in the AI-generated drug discovery landscape, has corralled $400 million in a Series C that triples its paper value from its last round of financing. I…Endpoints · 13d ago